US 7553962
Cross-linked glycopeptide-cephalosporin antibiotics
granted A61KA61K31/545A61K38/00
Quick answer
US patent 7553962 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/545, A61K38/00, A61P, A61P31/00